GSK's Quesnelle Brings Expertise In Switch To Consulting Arena
This article was originally published in The Tan Sheet
Executive Summary
Through 30 years working in the pharmaceutical industry, George Quesnelle became a leading expert on the Rx-to-OTC switch process. At GlaxoSmithKline, he led the charge in switching Nicorette and NicoDerm CQ smoking cessation products, as well as alli for weight loss.
You may also be interested in...
For Successful OTC Switch Proposals, A Good Offense Defends Against Doubters
OTC switch sponsors should identify adversaries early in the application switch process so they can counter arguments that could derail their switch, s consultant advises. Some switches fail because firms target regulatory approval and do little on marketplace performance.
For Successful OTC Switch Proposals, A Good Offense Defends Against Doubters
OTC switch sponsors should identify adversaries early in the application switch process so they can counter arguments that could derail their switch, s consultant advises. Some switches fail because firms target regulatory approval and do little on marketplace performance.
GSK Upbeat On Alli In EU As Global Consumer Sales Show Healthy Gains
Alli is off to the races in Europe, where it is generating high sales since launching in April, GlaxoSmithKline says